Recently, a metabolomic study analyzed a cohort of 16 pediatric AML patients, evenly distributed in wild-type FLT3 and mutated FLT3-ITD, and asserted a direct correlation between metabolic features and FLT3 mutational background, with 209 features that were differentially expressed between the groups. The gene discussed is FLT3; the disease is acute myeloid leukemia.